Global Natural Killer Cell Therapies Professional Survey Report 2022 Forecast to 2027

Code: RW00014672842
Multimarket Insight
Jul-2022
Life Sciences
102 Pages

Natural killer cell therapy is a type of cellular immunotherapy, just like CAR T-cell therapy. Like T-cells, NK cells form part of the immune system and attack germs and other malignant cells. Unlike T-cells, however, NK cells are not tailored to specific antigens.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Natural Killer Cell Therapies industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.

Market Segment by Product Type
NK Cell Therapies
NK Cell Directed Antibodies

Market Segment by Product Application
Cancer
Gastrointestinal Diseases
Others

Finally, the report provides detailed profile and data information analysis of leading company.
Nektar Therapeutics
Kiadis Pharma
Chipscreen Biosciences
Innate
Dragonfly Therapeutics
Affimed
Nkarta Therapeutics
Glycostem
Fate Therapeutics
NantWorks
Fortress Biotech

Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.

Research Objectives
1.To study and analyze the global Natural Killer Cell Therapies consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Natural Killer Cell Therapies market by identifying its various subsegments.
3.Focuses on the key global Natural Killer Cell Therapies manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Natural Killer Cell Therapies with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Natural Killer Cell Therapies submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

Global Natural Killer Cell Therapies Professional Survey Report Report 2022, Forecast to 2027

1 Market Study Overview
1.1 Study Objectives
1.2 Natural Killer Cell Therapies Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation

2 Global Trend Summary
2.1 Natural Killer Cell Therapies Segment by Type
2.1.1 NK Cell Therapies
2.1.2 NK Cell Directed Antibodies
2.2 Market Analysis by Application
2.2.1 Cancer
2.2.2 Gastrointestinal Diseases
2.2.3 Others
2.3 Global Natural Killer Cell Therapies Market Comparison by Regions (2017-2027)
2.3.1 Global Natural Killer Cell Therapies Market Size (2017-2027)
2.3.2 North America Natural Killer Cell Therapies Status and Prospect (2017-2027)
2.3.3 Europe Natural Killer Cell Therapies Status and Prospect (2017-2027)
2.3.4 Asia-pacific Natural Killer Cell Therapies Status and Prospect (2017-2027)
2.3.5 South America Natural Killer Cell Therapies Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Natural Killer Cell Therapies Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Natural Killer Cell Therapies Industry Impact
2.5.1 Natural Killer Cell Therapies Business Impact Assessment - Covid-19
2.5.2 Market Trends and Natural Killer Cell Therapies Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19

3 Competition by Manufacturer
3.1 Global Natural Killer Cell Therapies Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Natural Killer Cell Therapies Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Natural Killer Cell Therapies Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Natural Killer Cell Therapies Manufacturer Market Share
3.5 Top 10 Natural Killer Cell Therapies Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Natural Killer Cell Therapies Market
3.7 Key Manufacturers Natural Killer Cell Therapies Product Offered
3.8 Mergers & Acquisitions Planning

4 Analysis of Natural Killer Cell Therapies Industry Key Manufacturers
4.1 Nektar Therapeutics
4.1.1 Company Details
4.1.2 Nektar Therapeutics Natural Killer Cell Therapies Product Introduction, Application and Specification
4.1.3 Nektar Therapeutics Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Nektar Therapeutics News
4.2 Kiadis Pharma
4.2.1 Company Details
4.2.2 Kiadis Pharma Natural Killer Cell Therapies Product Introduction, Application and Specification
4.2.3 Kiadis Pharma Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Kiadis Pharma News
4.3 Chipscreen Biosciences
4.3.1 Company Details
4.3.2 Chipscreen Biosciences Natural Killer Cell Therapies Product Introduction, Application and Specification
4.3.3 Chipscreen Biosciences Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Chipscreen Biosciences News
4.4 Innate
4.4.1 Company Details
4.4.2 Innate Natural Killer Cell Therapies Product Introduction, Application and Specification
4.4.3 Innate Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Innate News
4.5 Dragonfly Therapeutics
4.5.1 Company Details
4.5.2 Dragonfly Therapeutics Natural Killer Cell Therapies Product Introduction, Application and Specification
4.5.3 Dragonfly Therapeutics Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Dragonfly Therapeutics News
4.6 Affimed
4.6.1 Company Details
4.6.2 Affimed Natural Killer Cell Therapies Product Introduction, Application and Specification
4.6.3 Affimed Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Affimed News
4.7 Nkarta Therapeutics
4.7.1 Company Details
4.7.2 Nkarta Therapeutics Natural Killer Cell Therapies Product Introduction, Application and Specification
4.7.3 Nkarta Therapeutics Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Nkarta Therapeutics News
4.8 Glycostem
4.8.1 Company Details
4.8.2 Glycostem Natural Killer Cell Therapies Product Introduction, Application and Specification
4.8.3 Glycostem Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Glycostem News
4.9 Fate Therapeutics
4.9.1 Company Details
4.9.2 Fate Therapeutics Natural Killer Cell Therapies Product Introduction, Application and Specification
4.9.3 Fate Therapeutics Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Fate Therapeutics News
4.10 NantWorks
4.10.1 Company Details
4.10.2 NantWorks Natural Killer Cell Therapies Product Introduction, Application and Specification
4.10.3 NantWorks Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 NantWorks News
4.11 Fortress Biotech
4.11.1 Company Details
4.11.2 Fortress Biotech Natural Killer Cell Therapies Product Introduction, Application and Specification
4.11.3 Fortress Biotech Natural Killer Cell Therapies Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Fortress Biotech News

5 Global Natural Killer Cell Therapies Sales Categorized by Regions
5.1 Global Natural Killer Cell Therapies Revenue, Sales and Market Share by Regions
5.1.1 Global Natural Killer Cell Therapies Sales and Market Share by Regions (2017-2022)
5.1.2 Global Natural Killer Cell Therapies Revenue and Market Share by Regions (2017-2022)
5.2 North America Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
5.3 Europe Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
5.5 South America Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)

6 North America Natural Killer Cell Therapies Market Size Categorized by Countries
6.1 North America Natural Killer Cell Therapies Sales, Revenue and Market Share by Countries
6.1.1 North America Natural Killer Cell Therapies Sales (Volume) by Countries (2017-2022)
6.1.2 North America Natural Killer Cell Therapies Revenue by Countries (2017-2022)
6.1.3 United States Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
6.1.4 Canada Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
6.1.5 Mexico Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
6.2 North America Natural Killer Cell Therapies Revenue (Value) by Manufacturers
6.3 North America Natural Killer Cell Therapies Sales and Market Share by Type (2017-2022)
6.4 North America Natural Killer Cell Therapies Sales Market Share by Application (2017-2022)

7 Europe Natural Killer Cell Therapies Market Size Categorized by Countries
7.1 Europe Natural Killer Cell Therapies Sales, Revenue and Market Share by Countries
7.1.1 Europe Natural Killer Cell Therapies Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Natural Killer Cell Therapies Revenue by Countries (2017-2022)
7.1.3 Germany Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
7.1.4 UK Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
7.1.5 France Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
7.1.6 Russia Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
7.1.7 Italy Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
7.1.8 Spain Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
7.2 Europe Natural Killer Cell Therapies Revenue (Value) by Manufacturers
7.3 Europe Natural Killer Cell Therapies Sales and Market Share by Type (2017-2022)
7.4 Europe Natural Killer Cell Therapies Sales Market Share by Application (2017-2022)

8 Asia-Pacific Natural Killer Cell Therapies Market Size Categorized by Countries
8.1 Asia-pacific Natural Killer Cell Therapies Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Natural Killer Cell Therapies Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Natural Killer Cell Therapies Revenue by Countries (2017-2022)
8.1.3 China Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
8.1.4 South Korea Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
8.1.5 Japan Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
8.1.6 Australia Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
8.1.7 India Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Natural Killer Cell Therapies Revenue (Value) by Manufacturers
8.3 Asia-pacific Natural Killer Cell Therapies Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Natural Killer Cell Therapies Sales Market Share by Application (2017-2022)

9 South America Natural Killer Cell Therapies Market Size Categorized by Countries
9.1 South America Natural Killer Cell Therapies Sales, Revenue and Market Share by Countries
9.1.1 South America Natural Killer Cell Therapies Sales (Volume) by Countries (2017-2022)
9.1.2 South America Natural Killer Cell Therapies Revenue by Countries (2017-2022)
9.1.3 Brazil Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
9.2 South America Natural Killer Cell Therapies Sales and Market Share by Type (2017-2022)
9.3 South America Natural Killer Cell Therapies Sales Market Share by Application (2017-2022)

10 Middle East and Africa Natural Killer Cell Therapies Market Size Categorized by Countries
10.1 Middle East and Africa Natural Killer Cell Therapies Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Natural Killer Cell Therapies Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Natural Killer Cell Therapies Revenue by Countries (2017-2022)
10.1.3 GCC Countries Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
10.1.4 Turkey Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
10.1.5 Egypt Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
10.1.6 South America Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Natural Killer Cell Therapies Sales and Market Share by Type
10.3 Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Application (2017-2022)

11 Global Natural Killer Cell Therapies Market Segment by Type
11.1 Global Natural Killer Cell Therapies Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Natural Killer Cell Therapies Sales and Market Share by Type (2017-2022)
11.1.2 Global Natural Killer Cell Therapies Revenue and Market Share by Type (2017-2022)
11.2 NK Cell Therapies Sales Growth Rate and Price
11.2.1 Global NK Cell Therapies Sales Growth Rate (2017-2022)
11.2.2 Global NK Cell Therapies Price (2017-2022)
11.3 NK Cell Directed Antibodies Sales Growth Rate and Price
11.3.1 Global NK Cell Directed Antibodies Sales Growth Rate (2017-2022)
11.3.2 Global NK Cell Directed Antibodies Price (2017-2022)

12 Global Natural Killer Cell Therapies Market Segment by Application
12.1 Global Natural Killer Cell Therapies Sales Market Share by Application (2017-2022)
12.2 Cancer Sales Growth Rate (2017-2022)
12.3 Gastrointestinal Diseases Sales Growth Rate (2017-2022)
12.4 Others Sales Growth Rate (2017-2022)

13 Global Natural Killer Cell Therapies Market Forecast
13.1 Global Natural Killer Cell Therapies Revenue, Sales and Growth Rate (2022-2027)
13.2 Natural Killer Cell Therapies Market Forecast by Regions (2022-2027)
13.2.1 North America Natural Killer Cell Therapies Market Forecast (2022-2027)
13.2.2 Europe Natural Killer Cell Therapies Market Forecast (2022-2027)
13.2.3 Asia-Pacific Natural Killer Cell Therapies Market Forecast (2022-2027)
13.2.4 South America Natural Killer Cell Therapies Market Forecast (2022-2027)
13.2.5 Middle East & Africa Natural Killer Cell Therapies Market Forecast (2022-2027)
13.3 Natural Killer Cell Therapies Market Forecast by Type (2022-2027)
13.3.1 Global Natural Killer Cell Therapies Sales Forecast by Type (2022-2027)
13.3.2 Global Natural Killer Cell Therapies Market Share Forecast by Type (2022-2027)
13.4 Natural Killer Cell Therapies Market Forecast by Application (2022-2027)
13.4.1 Global Natural Killer Cell Therapies Sales Forecast by Application (2022-2027)
13.4.2 Global Natural Killer Cell Therapies Market Share Forecast by Application (2022-2027)

14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis

15 Natural Killer Cell Therapies Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Natural Killer Cell Therapies Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers

List of Tables and Figures

Figure Product Picture Natural Killer Cell Therapies
Figure Market Concentration Ratio and Market Maturity Analysis of Natural Killer Cell Therapies
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Natural Killer Cell Therapies Market Size by Type
Figure Global Market Share of Natural Killer Cell Therapies by Type in 2021
Figure NK Cell Therapies Picture
Figure NK Cell Directed Antibodies Picture
Table Global Natural Killer Cell Therapies Market Size (Volume) by Application
Figure Cancer Picture
Figure Gastrointestinal Diseases Picture
Figure Others Picture
Table Global Natural Killer Cell Therapies Comparison by Regions (M USD) 2017-2027
Figure Global Natural Killer Cell Therapies Market Size (Million US$) (2017-2027)
Figure North America Natural Killer Cell Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Natural Killer Cell Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Natural Killer Cell Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Natural Killer Cell Therapies Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Natural Killer Cell Therapies Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Natural Killer Cell Therapies Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Natural Killer Cell Therapies Sales by Manufacturer (2017-2022)
Figure Global Natural Killer Cell Therapies Sales Market Share by Manufacturer in 2021
Table Global Natural Killer Cell Therapies Revenue by Manufacturer (2017-2022)
Figure Global Natural Killer Cell Therapies Revenue Market Share by Manufacturer in 2021
Table Global Natural Killer Cell Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Natural Killer Cell Therapies Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Natural Killer Cell Therapies Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Natural Killer Cell Therapies Market
Table Key Manufacturers Natural Killer Cell Therapies Product Type
Table Mergers & Acquisitions Planning
Table Nektar Therapeutics Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Nektar Therapeutics
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Nektar Therapeutics 2017-2022
Table Nektar Therapeutics Main Business
Table Nektar Therapeutics Recent Development
Table Kiadis Pharma Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Kiadis Pharma
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Kiadis Pharma 2017-2022
Table Kiadis Pharma Main Business
Table Kiadis Pharma Recent Development
Table Chipscreen Biosciences Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Chipscreen Biosciences
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Chipscreen Biosciences 2017-2022
Table Chipscreen Biosciences Main Business
Table Chipscreen Biosciences Recent Development
Table Innate Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Innate
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Innate 2017-2022
Table Innate Main Business
Table Innate Recent Development
Table Dragonfly Therapeutics Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Dragonfly Therapeutics
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Dragonfly Therapeutics 2017-2022
Table Dragonfly Therapeutics Main Business
Table Dragonfly Therapeutics Recent Development
Table Affimed Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Affimed
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Affimed 2017-2022
Table Affimed Main Business
Table Affimed Recent Development
Table Nkarta Therapeutics Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Nkarta Therapeutics
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Nkarta Therapeutics 2017-2022
Table Nkarta Therapeutics Main Business
Table Nkarta Therapeutics Recent Development
Table Glycostem Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Glycostem
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Glycostem 2017-2022
Table Glycostem Main Business
Table Glycostem Recent Development
Table Fate Therapeutics Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Fate Therapeutics
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Fate Therapeutics 2017-2022
Table Fate Therapeutics Main Business
Table Fate Therapeutics Recent Development
Table NantWorks Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of NantWorks
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of NantWorks 2017-2022
Table NantWorks Main Business
Table NantWorks Recent Development
Table Fortress Biotech Company Profile
Table Natural Killer Cell Therapies Product Introduction, Application and Specification of Fortress Biotech
Table Natural Killer Cell Therapies Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Fortress Biotech 2017-2022
Table Fortress Biotech Main Business
Table Fortress Biotech Recent Development
Figure Global Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Global Natural Killer Cell Therapies Revenue and Growth Rate (2017-2022)
Table Global Natural Killer Cell Therapies Sales by Regions (2017-2022)
Figure Global Natural Killer Cell Therapies Sales Market Share by Regions in 2021
Table Global Natural Killer Cell Therapies Revenue by Regions (2017-2022)
Figure Global Natural Killer Cell Therapies Revenue Market Share by Regions in 2021
Figure North America Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Europe Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Asia-pacific Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure South America Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure North America Natural Killer Cell Therapies Revenue and Growth Rate (2017-2022)
Table North America Natural Killer Cell Therapies Sales (Volume) by Countries (2017-2022)
Table North America Natural Killer Cell Therapies Sales Market Share by Countries (2017-2022)
Figure North America Natural Killer Cell Therapies Sales Market Share by Countries in 2021
Table North America Natural Killer Cell Therapies Revenue by Countries (2017-2022)
Table North America Natural Killer Cell Therapies Revenue Market Share by Countries (2017-2022)
Figure North America Natural Killer Cell Therapies Revenue Market Share by Countries in 2021
Figure United States Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Canada Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Mexico Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Table North America Natural Killer Cell Therapies Revenue by Manufacturer (2021)
Figure North America Natural Killer Cell Therapies Revenue Market Share by Manufacturer in 2021
Table North America Natural Killer Cell Therapies Sales by Type (2017-2022)
Table North America Natural Killer Cell Therapies Sales Share by Type (2017-2022)
Table North America Natural Killer Cell Therapies Sales by Application (2017-2022)
Table North America Natural Killer Cell Therapies Sales Share by Application (2017-2022)
Figure Europe Natural Killer Cell Therapies Revenue and Growth Rate (2017-2022)
Table Europe Natural Killer Cell Therapies Sales (Volume) by Countries (2017-2022)
Table Europe Natural Killer Cell Therapies Sales Market Share by Countries (2017-2022)
Figure Europe Natural Killer Cell Therapies Sales Market Share by Countries in 2021
Table Europe Natural Killer Cell Therapies Revenue by Countries (2017-2022)
Table Europe Natural Killer Cell Therapies Revenue Market Share by Countries (2017-2022)
Figure Europe Natural Killer Cell Therapies Revenue Market Share by Countries in 2021
Figure Germany Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure UK Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure France Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Russia Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Italy Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Spain Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Table Europe Natural Killer Cell Therapies Revenue by Manufacturer (2021)
Figure Europe Natural Killer Cell Therapies Revenue Market Share by Manufacturer in 2021
Table Europe Natural Killer Cell Therapies Sales by Type (2017-2022)
Table Europe Natural Killer Cell Therapies Sales Share by Type (2017-2022)
Table Europe Natural Killer Cell Therapies Sales by Application (2017-2022)
Table Europe Natural Killer Cell Therapies Sales Share by Application (2017-2022)
Figure Asia-pacific Natural Killer Cell Therapies Revenue and Growth Rate (2017-2022)
Table Asia-pacific Natural Killer Cell Therapies Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Natural Killer Cell Therapies Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Natural Killer Cell Therapies Sales Market Share by Countries in 2021
Table Asia-pacific Natural Killer Cell Therapies Revenue by Countries (2017-2022)
Table Asia-pacific Natural Killer Cell Therapies Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Natural Killer Cell Therapies Revenue Market Share by Countries in 2021
Figure China Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure South Korea Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Japan Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Australia Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure India Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Southeast Asia Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Table Asia-pacific Natural Killer Cell Therapies Revenue by Manufacturer (2021)
Figure Asia-pacific Natural Killer Cell Therapies Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Natural Killer Cell Therapies Sales by Type (2017-2022)
Table Asia-pacific Natural Killer Cell Therapies Sales Share by Type (2017-2022)
Table Asia-pacific Natural Killer Cell Therapies Sales by Application (2017-2022)
Table Asia-pacific Natural Killer Cell Therapies Sales Share by Application (2017-2022)
Figure South America Natural Killer Cell Therapies Revenue and Growth Rate (2017-2022)
Table South America Natural Killer Cell Therapies Sales (Volume) by Countries (2017-2022)
Table South America Natural Killer Cell Therapies Sales Market Share by Countries (2017-2022)
Figure South America Natural Killer Cell Therapies Sales Market Share by Countries in 2019
Table South America Natural Killer Cell Therapies Revenue by Countries (2017-2022)
Table South America Natural Killer Cell Therapies Revenue Market Share by Countries (2017-2022)
Figure South America Natural Killer Cell Therapies Revenue Market Share by Countries in 2019
Figure Brazil Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Table South America Natural Killer Cell Therapies Sales by Type (2017-2022)
Table South America Natural Killer Cell Therapies Sales Share by Type (2017-2022)
Table South America Natural Killer Cell Therapies Revenue by Type (2017-2022)
Table South America Natural Killer Cell Therapies Revenue Share by Type (2017-2022)
Table South America Natural Killer Cell Therapies Sales by Application (2017-2022)
Table South America Natural Killer Cell Therapies Sales Share by Application (2017-2022)
Figure Middle East and Africa Natural Killer Cell Therapies Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Natural Killer Cell Therapies Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Natural Killer Cell Therapies Sales Market Share by Countries in 2019
Table Middle East and Africa Natural Killer Cell Therapies Revenue by Countries (2017-2022)
Table Middle East and Africa Natural Killer Cell Therapies Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Natural Killer Cell Therapies Revenue Market Share by Countries in 2019
Figure GCC Countries Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Turkey Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure Egypt Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Figure South Africa Natural Killer Cell Therapies Sales and Growth Rate (2017-2022)
Table Middle East and Africa Natural Killer Cell Therapies Sales by Type (2017-2022)
Table Middle East and Africa Natural Killer Cell Therapies Sales Share by Type (2017-2022)
Table Middle East and Africa Natural Killer Cell Therapies Revenue by Type (2017-2022)
Table Middle East and Africa Natural Killer Cell Therapies Revenue Share by Type (2017-2022)
Table Middle East and Africa Natural Killer Cell Therapies Sales by Application (2017-2022)
Table Middle East and Africa Natural Killer Cell Therapies Sales Share by Application (2017-2022)
Table Global Natural Killer Cell Therapies Sales by Type (2017-2022)
Table Global Natural Killer Cell Therapies Sales Market Share by Type (2017-2022)
Figure Global Natural Killer Cell Therapies Sales Market Share by Type in 2021
Table Global Natural Killer Cell Therapies Revenue by Type (2017-2022)
Table Global Natural Killer Cell Therapies Revenue Market Share by Type (2017-2022)
Figure Global Natural Killer Cell Therapies Revenue Market Share by Type in 2019
Figure Global NK Cell Therapies Sales Growth Rate (2017-2022)
Figure Global NK Cell Therapies Price (2017-2022)
Figure Global NK Cell Directed Antibodies Sales Growth Rate (2017-2022)
Figure Global NK Cell Directed Antibodies Price (2017-2022)
Table Global Natural Killer Cell Therapies Sales by Application (2017-2022)
Table Global Natural Killer Cell Therapies Sales Market Share by Application (2017-2022)
Figure Global Natural Killer Cell Therapies Sales Market Share by Application in 2021
Figure Global Cancer Sales Growth Rate (2017-2022)
Figure Global Gastrointestinal Diseases Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Natural Killer Cell Therapies Sales and Growth Rate (2022-2027)
Figure Global Natural Killer Cell Therapies Revenue and Growth Rate (2022-2027)
Table Global Natural Killer Cell Therapies Sales Forecast by Regions (2017-2022)
Table Global Natural Killer Cell Therapies Market Share Forecast by Regions (2017-2022)
Figure North America Sales Natural Killer Cell Therapies Market Forecast (2022-2027)
Figure Europe Sales Natural Killer Cell Therapies Market Forecast (2022-2027)
Figure Asia-Pacific Sales Natural Killer Cell Therapies Market Forecast (2022-2027)
Figure South America Sales Natural Killer Cell Therapies Market Forecast (2022-2027)
Figure Middle East & Africa Sales Natural Killer Cell Therapies Market Forecast (2022-2027)
Table Global Natural Killer Cell Therapies Sales Forecast by Type (2022-2027)
Table Global Natural Killer Cell Therapies Market Share Forecast by Type (2022-2027)
Table Global Natural Killer Cell Therapies Sales Forecast by Application (2022-2027)
Table Global Natural Killer Cell Therapies Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Natural Killer Cell Therapies
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List

Nektar Therapeutics
Kiadis Pharma
Chipscreen Biosciences
Innate
Dragonfly Therapeutics
Affimed
Nkarta Therapeutics
Glycostem
Fate Therapeutics
NantWorks
Fortress Biotech

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE